US Patent Issued to Nanjing GenScript Biotech on Sept. 1 for "Monoclonal antibody-cytokine fusion protein dimer and application thereof" (Chinese, Singaporean Inventors)

ALEXANDRIA, Va., Sept. 1 -- United States Patent no. 12,723,080, issued on Sept. 1, was assigned to Nanjing GenScript Biotech Co. Ltd. (Nanjing, China).

"Monoclonal antibody-cytokine fusion protein dimer and application thereof" was invented by Zhongdao Li (Nanjing, China), Liusong Yin (Nanjing, China), Zhenyu Liu (Nanjing, China), Tielin Zhou (Singapore) and Zhuo Fang (Nanjing, China).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided are a monoclonal antibody-cytokine fusion protein dimer and an application thereof. The monoclonal antibody comprises two heavy chains, the fusion protein dimer comprises a first heavy chain polypeptide chain and a second heavy chain polypeptide chain, wherein one heavy ch...